Having demonstrated expression of the apelin system throughout the human kidney, next we measured apelin and ELA concentrations in patients with nondiabetic CKD (n = 128) and age‐ and sex‐matched healthy volunteers (n = 27; Table 1). Here, APLN is linked to chronic kidney disease.